Drug Shows Promise for Hardtotreat Rare Blood Disorder
Drug Shows Promise for Hard-to-treat, Rare Blood Disorder
In a first-in-human
clinical trial, the investigational
drug sutimlimab appeared to be effective in treating cold agglutinin disease.
Original Article: Drug Shows Promise for Hard-to-treat, Rare Blood Disorder
More From BioPortfolio on "Drug Shows Promise for Hard-to-treat, Rare Blood Disorder"